Topical pain relief medications are pain killers that are designed to relieve pain as they are composed of different ingredients such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDS), salicylates, capsaicin, and others. These products have a heating or cooling effect that stimulate the nerves near the pain point and relieve pain. When pain is localized, patients highly prefer topical treatments as adjunctive therapy, which can be as effective as oral treatments and cause fewer side effects. They are directly applied, rubbed, or sprayed on the skin over painful muscles or joints.
The U.S. Topical Pain Relief Market was valued at $2,324 million in 2017, and is projected to reach $3,730 million in 2025, registering a CAGR of 6.0% from 2018 to 2025.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5356
The key factors that drive the U.S. topical pain relief market growth includes increase in prevalence of arthritis, rise in number of patient with joint pain, diabetic neuropathy, and other bone disorders across the U.S. In addition, rise in geriatric population, fewer side effects caused by topical pain relief as compared to oral medications, easy availability of medication, and high adoption of topical pain relief products by sportsperson. However, topical pain relief medications can cause irritation, and these products are usually characterized by an unpleasant odor, which impede the market growth. Conversely, the development of an online platform for topical therapeutics is expected to provide lucrative growth opportunities for the U.S. market.
The non-opioids segment accounted for the largest share in 2017 owing to high usage in treatment of pain and lesser side effects as compared to opioids. By type, the over-the counter pain relief segment dominated the U.S. topical pain relief market in terms of revenue in 2017 and the trend is projected to continue throughout the forecast period.
The utilization rate of cream pain relief products is high owing to high availability of these products with high success rate and lesser side effects. However, the patch pain relief products segment is expected to grow at a CAGR of 7.6% during the forecast period.
The pharmacies & drug stores segment is the largest segment in the U.S. topical pain relief market, and is estimated to expand at a CAGR of 5.6% during the forecast period. On the other hand, the e-commerce segment is anticipated to record highest CAGR during the forecast period.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5356
The Major Key Players Are:
Johnson & Johnson, Novartis AG, GlaxoSmithKline Plc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Topical BioMedics, Inc., AdvaCare Pharma, Sun Pharmaceutical Industries Ltd., and Nestle S.A.